FactEvidence 1
part ofKeytruda
No public evidence summary is available.
STAT · 2026-10-07 22:06
View evidence
- MediaSTAT2026-10-07 22:06View source
MRK NYSE
Merck
Description
MRK · NYSEThe Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany.
Wikipedia · CC BY-SA 4.0
- Headquarters
- US
- Reporting currency
- USD
- Website
- Website
Structure of Merck
Merck
Company
5 connections
UpstreamSupply and dependency
OwnProducts and technology
PeersCompetition and partners
Relationship began
MerckCompany · 5 connections
Layer 1UpstreamSupply and dependency1
PeersCompetition and partners2
OwnProducts and technology2
Relations
Arrows show the direction of the relationship. Filter to focus on a business area.
- 思璞锐agreement with →MerckCompany · 思璞锐Evidence 1Fact55%
View evidence
- Media钛媒体2026-10-07 08:56View source
- Keytrudapart of →MerckProduct · KeytrudaEvidence 1Fact55%
View evidence
- MediaSTAT2026-10-07 22:06View source
- Company · TrebellarEvidence 1Fact55%
View evidence
- MediaCommercial Observer2026-10-05 19:57View source
- Product · CapvaxiveEvidence 1Fact55%
View evidence
- MediaSTAT2026-10-05 20:19View source
- Vaxcytecompetes with →MerckCompany · VaxcyteEvidence 1Fact55%
View evidence
- MediaSTAT2026-10-05 20:19View source
Showing 1 to 5 of 5
Claims
Read the assertion alongside its sources. Expand a row to inspect the evidence.
FactEvidence 1
agreement with思璞锐
No public evidence summary is available.
钛媒体 · 2026-10-07 08:56
View evidence
- Media钛媒体2026-10-07 08:56View source
FactEvidence 1
customer ofTrebellar
No public evidence summary is available.
Commercial Observer · 2026-10-05 19:57
View evidence
- MediaCommercial Observer2026-10-05 19:57View source
FactEvidence 1
producesCapvaxive
No public evidence summary is available.
STAT · 2026-10-05 20:19
View evidence
- MediaSTAT2026-10-05 20:19View source
FactEvidence 1
competes withVaxcyte
No public evidence summary is available.
STAT · 2026-10-05 20:19
View evidence
- MediaSTAT2026-10-05 20:19View source
Showing 1 to 5 of 5
Market and valuation
Valuation data is available on Pro and Research.
Included in ProFilings
10-QPeriod end 2026-06-30Filed 2026-08-078-KPeriod end 2026-08-04Filed 2026-08-048-KPeriod end 2026-05-26Filed 2026-05-288-KPeriod end 2026-05-22Filed 2026-05-2210-QPeriod end 2026-03-31Filed 2026-05-048-KPeriod end 2026-04-30Filed 2026-04-3010-KPeriod end 2025-12-31Filed 2026-02-248-KPeriod end 2026-02-03Filed 2026-02-038-KPeriod end 2025-12-04Filed 2025-12-0410-QPeriod end 2025-09-30Filed 2025-11-058-KPeriod end 2025-10-30Filed 2025-10-308-KPeriod end 2025-09-09Filed 2025-09-0910-QPeriod end 2025-06-30Filed 2025-08-058-KPeriod end 2025-07-25Filed 2025-07-298-KPeriod end 2025-05-27Filed 2025-05-2910-QPeriod end 2025-03-31Filed 2025-05-028-KPeriod end 2025-04-24Filed 2025-04-2410-KPeriod end 2024-12-31Filed 2025-02-258-KPeriod end 2025-02-04Filed 2025-02-048-KPeriod end 2024-11-19Filed 2024-11-22
Not available: Company signals · Financials · Guidance